Trace a drug shortage to its manufacturing, quality or supply chain root cause using structured analysis.
Healthcare & Pharmaceutical Management
Drug Shortage Root-Cause Analysis and Mitigation Planning
Build the skills to trace a drug shortage back to its manufacturing or supply chain root cause and design a mitigation plan that protects patient access during the event.
🗓️Duration5 training days
📚Content4 modules · 8 sessions
🎓On completionAccredited attendance certificate
About the programme
Course Overview
A drug shortage rarely has one cause: a single-source active ingredient, a quality-related manufacturing shutdown and a demand spike can combine to leave a hospital pharmacy without a critical medicine within weeks. This course builds the investigative and planning skills that turn a shortage from a crisis into a managed event. Participants apply structured root-cause analysis techniques to real shortage patterns, map supply chains to find single-source dependencies before they cause a failure, and build early warning systems that flag emerging risk from manufacturing, quality and logistics data. The programme then covers the clinical side of a shortage: allocation and rationing decisions, therapeutic substitution protocols, and clear communication to clinicians, patients and regulators while a shortage is active. The final sessions look beyond the immediate event to supply chain diversification, buffer stock strategy and the shortage reporting obligations that connect a single organisation's response to a wider resilience effort across the sector.
Expected Learning Outcomes
Map a product's supply chain to identify single-source dependencies before they cause a shortage.
Build an early warning system that flags shortage risk from manufacturing and logistics signals.
Design an allocation protocol that distributes limited supply according to clinical priority.
Select therapeutic substitution options that maintain patient safety during a shortage event.
Communicate shortage status and mitigation steps clearly to clinicians, patients and regulators.
Develop a resilience plan that diversifies supply and sets buffer stock levels for critical medicines.
Who Should Attend
Hospital and health system pharmacy directors managing medicine supply continuity.
Pharmaceutical supply chain and procurement managers assessing shortage risk.
Quality and manufacturing staff investigating shortage root causes at a production site.
Regulatory affairs professionals responsible for shortage notification obligations.
Clinical pharmacists making allocation and therapeutic substitution decisions.
Emergency preparedness planners building medicine supply resilience strategies.
Course Modules
Select any module to see its sessions and points.
01Understanding Drug Shortage Causes and Early Warning
2 sessions · 8 points
Session 1Manufacturing, Quality and Supply Chain Root Causes
- Classify shortage causes into manufacturing capacity, quality failure, raw material and demand categories.
- Assess how a quality-related shutdown at a single facility can cascade into a market-wide shortage.
- Review case patterns where active pharmaceutical ingredient dependency created shortage risk.
- Identify the lead indicators that typically appear before a shortage becomes visible to pharmacies.
Session 2Shortage Signal Detection and Early Warning Systems
- Design a monitoring dashboard that tracks manufacturing, inventory and demand signals together.
- Set threshold triggers that prompt investigation before stock levels reach a critical point.
- Build a reporting channel that captures shortage signals from pharmacy and procurement staff.
- Evaluate external shortage databases and regulator notifications as early warning inputs.
02Root-Cause Analysis Methods for Shortage Events
2 sessions · 8 points
Session 1Structured Root-Cause Analysis Techniques
- Apply a five-whys or fishbone analysis to trace a shortage back to its originating cause.
- Distinguish an immediate trigger from the underlying systemic weakness that allowed it to occur.
- Document a root-cause investigation in a format that supports corrective action planning.
- Test proposed root causes against manufacturing, quality and distribution records.
Session 2Supply Chain Mapping and Single-Source Dependency Assessment
- Map a product's supply chain from raw material through to finished dose distribution.
- Identify single-source suppliers and single-site manufacturing as concentrated points of risk.
- Score suppliers and sites on a risk matrix that combines capacity, quality history and geography.
- Recommend qualification of a second source where dependency risk is judged unacceptable.
03Shortage Response and Clinical Mitigation
2 sessions · 8 points
Session 1Allocation, Rationing and Therapeutic Substitution Decisions
- Design an allocation framework that prioritises limited supply by clinical urgency and need.
- Evaluate therapeutic alternatives for safety, dosing and administration differences before substitution.
- Set criteria for when conservation measures, such as extended dosing intervals, are clinically acceptable.
- Coordinate allocation decisions across departments to avoid local stockpiling that worsens the shortage.
Session 2Communicating Shortages to Clinicians, Patients and Regulators
- Draft a clinician communication that explains the shortage, its expected duration and substitution guidance.
- Prepare patient-facing information that addresses safety and continuity of care concerns.
- Meet shortage notification obligations to regulators within the required reporting timeframe.
- Coordinate public statements with regulators and other affected organisations during a shortage.
04Building Long-Term Shortage Resilience
2 sessions · 8 points
Session 1Supply Chain Diversification and Buffer Stock Strategy
- Set buffer stock levels for critical medicines based on demand variability and lead times.
- Build a business case for qualifying alternative suppliers or manufacturing sites.
- Assess the cost and resilience trade-offs of dual sourcing against a single dominant supplier.
- Plan inventory visibility across a network to detect emerging shortages sooner.
Session 2Regulatory Reporting and Cross-Industry Resilience Planning
- Apply shortage reporting requirements set by regulators such as the FDA and the EMA.
- Participate in cross-industry information sharing that flags shortage risk earlier.
- Build an organisational shortage response plan with defined roles and escalation triggers.
- Review a past shortage response to identify improvements for the resilience plan.
What the participant receives
4 course modules
A structured syllabus
8 training sessions
across 5 days
32 detailed points
Applied, detailed content
Accredited attendance certificate
On completing the programme
Complete your registration
We will contact you within one business day to confirm.
Ready to start?
Reserve your seat and start building the skill.